© 2020 DHI Cluster. All rights reserved.
MORE-Darzalas Foundation is a non-profit institution established in June 2015 in Varna.
The first part of the foundation´s name is an abbreviation: multidisciplinary oncological conversations and extracts. It refers to the main goal of the foundation: to improve the mindset, methodology and practice in the field of Bulgarian clinical oncology. The second part of its name is the ancient Thracian god Darzalas, considered the patron saint of the ancient city of Odessos, today’s Varna. The Indo-European root ther – brave is inserted in its name and the Old Bulgarian language has carried it through the centuries in the verb daring – I dare. This symbolism refers to the annual nominations with which the foundation selects individuals and presents the Wreath of Courage Award – for contribution to Bulgarian clinical oncology.
MORE-Darzalas Foundation functions as a non-governmental oncology project designed to work in areas with the most sensitive dysfunction of official state institutions. Without claiming alternative activities, the foundation rehabilitates most of the institutional inertia in national oncology.
The Association of Research-based Pharmaceutical Manufacturers in Bulgaria (ARPharM) was established in 1996 in Sofia as a non-profit organization. The Members of ARPharM are 24 research-oriented manufacturers of medicines from all over Europe, US and Japan, investing in the development of the pharmaceutical industry. The main priority of the Association is to contribute to the safety and supply of better human health and human life providing high-quality medical products for prevention, diagnostics and treatment of diseases. For the purposes of achieving this aim, the Association stands up and works for the good reputation of the pharmaceutical industry; promotes the contribution to the developments in the field of pharmacy; encourages any collaboration leading to improvement of health and prosperity of Bulgarian people; supports the appropriate governmental institutions and organizations in that respect; maintains and develops activities related to the pharmaceutical and medical research in Bulgaria for the reasons of international standards adoption. The Association works as a self-governed organization, which strives to provide for the fair competition among its members while preserving and adhering to the principles of professional ethics, industrial and intellectual property, observing the regulations, rules and standards in the medical products manufacturing as well as to contribute to the enhancement of the existing regulative and legal system in Bulgaria.
ARPharM makes every effort to create an official mechanism for continuous collaboration between the Association and the respective institutions in Bulgaria. It acts as an official communication channel between its members and the society regarding the questions connected with their activity applying for that purpose the means of public information. It creates active relationships with the national, European and world organizations with similar aims for exchange of information and experience.
The Association of Research-based Pharmaceutical Manufacturers in Bulgaria was admitted to associate membership into the European Federation during the session of the Managing Board of EFPIA held on 30 November, 2001. ARPharM is among the first similar associations from Central and Eastern Europe invited to associate membership into the European Federation of Pharmaceutical Industries and Associations (EFPIA). The federation brings together full members national associations of the pharmaceutical industry as well as members with a Liaison Status and number of pharmaceutical manufacturers whose priority is research, development and production of medical articles for human medicine in Europe.
The Association of the Research-based Pharmaceutical Manufacturers in Bulgaria (ARPharM) has been uniting for more than 20 years research-oriented medicines manufacturers from all over the world represented in the Republic of Bulgaria.
The fundamental priority of ARPharM is to contribute to the protection and safeguarding of human health and to provide for the higher quality of life of every Bulgarian citizen through ensured access to innovative along with already well-established high-quality, effective and safe medicines manufactured according to the highest international standards.
Aptuso is a Bulgarian company with a focus on healthcare softwares and applications development. The company provides a combination of healthcare solutions such as Hospital Information System that covers all regulations and restrictions, Electronic Medical Record, Laboratories, ePrescriptions and Therapies, eReferrals, Home Care and Telemedicine, Population Health Management based on Big Data structure and Machine Learning algorithms which are must to cover the needs of hospitals and medical centres, medical universities, patients, governments and insurance companies.
100% web based platform, fully-integrated, easy to use, scalable Turn Key Solution. Aptuso’s main idea is to ensure data integrity, security and to enforce ethical exchange not only in traditional medical research, but also in healthcare management on any level, from hospitals, to regional, national and global level. Our mission is to move the patients into the center of the healthcare, to establish frames of the gathered patients data from the specialists, prevention based on sustainable data and GenChain analysis.
DIASYST is the world’s first comprehensive chronic diseases remote monitoring and pharmacotherapy management platform.
DIASYST engages patients to collect critical medical information in real-time, analyzes the data with algorithms based on the latest clinical guidelines, and provides pharmacotherapy recommendations for the healthcare team to make quick, safe, effective, and individualized treatment decisions for their patients. Currently we are focused on diabetes and hypertension. Weight management, hyperlipidemia and other chronic diseases in our future roadmap.
DIASYST has very high patient engagement and positive user feedback, visible glucose improvement within 1 month, limit hypoglycemia to reduce emergency department visits and costs. Pharmacotherapy approach sustains longer-term results compared to behavior, diet, exercise-based approaches. By having the necessary information on a daily basis, DIASYST saves time on phone calls and allows for more patient care in the clinic. Patients benefit by knowing that accountability still exists, even when not being physically in the office.
Тhe most popular medical media group in Bulgaria
Medical News consists of the following websites – www.medicalnews.bg and www.zdravennavigator.bg.
MedicalNews.bg publishes a daily digest of the essential evidence-based medical news, scientific manuscripts, healthcare analysis, and continuous medical education for doctors. The authors are professional physicians. Medical News issues scientific journals and organizes scientific webinars.
ZdravenNavigator.bg is focused on general practitioners and pharmacists in Bulgaria. This is the only media reporting from all medical congresses, conferences, and symposia in the country.
Medical News and ZdravenNavigator are the only specialized websites in Bulgaria for doctors and healthcare professionals. The media group has more than 300 000 page views and 100 000 unique visits per month. Moreover, we have a database of more than 18 000 registered doctors (>60% of the doctors in Bulgaria).
Novo Nordisk is driving change to defeat diabetes and other serious chronic deceases
Novo Nordisk is a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark.
Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, and rare blood and rare endocrine diseases.
We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure the diseases we treat.
DR ALEXANDER SIMIDCHIEV
Non-Invasive Diagnosis Department Head, Ministry of Interior’s Medical Institute
Dr. Alexander Simidchiev has three medical specialties, but he is most passionate about pulmonology. He is the Head of the Department of Non-Invasive Diagnosis at the Ministry of the Interior’s Medical Institute, as well as part of the Pulmonology Department and the Laboratory for Functional Respiratory Testing of UB Lozenets, a member of the Bulgarian Society of Pulmonary Diseases and the European Respiratory Society, as well as a former chief respirator GlaxoSmithKline Canada. He has specialized in the Rouland Clinic in Essen, Germany and the Charite Hospital in Paris, France.
He is also the creator of the unique for the country web-based course in Digital Medicine, which he has been leading at Plovdiv Medical University for 3 years.
DR RADOSLAV MANGALDJIEV
Medical Oncology Department Head, Oncological Diseases Specialized Hospital
Dr. Radoslav Mangaldzhiev is Head of the Department of Medical Oncology at the Specialized Hospital for Oncological Diseases in Sofia. He is a member of the Bulgarian Cancer Scientific Society (BCSS), the European Society for Medical Oncology (ESMO), the Bulgarian Association for Chemotherapy. President of the Association of Medical Oncologists. Dr. Mangaldzhiev graduated from the Medical University in Sofia in 1996. He has a specialty of medical oncology and a specialty of dermatology and venereology.
PROF. IVO PETROV
Cardiology and Angiology Department Head, Acibadem City Clinic, Sofia
Prof. Dr. Ivo Petrov is Head of Cardiology and Angiology Department at Acibadem City Clinic Sofia. He has degrees in Internal Medicine, Cardiology and Healthcare Management. He is experienced cardiologist with professional qualification in non-invasive and invasive cardiology. He completed post-graduate medical course in echo stress testing and intravascular echocardiography in Wiesbaden, Germany and in 1999-2000 he was awarded a fellowship to specialize in invasive cardiology and radiology in the Institute of Cardiology and Cardio-Vascular Surgery sponsored by the Favaloro Foundation in Buenos Aires, Argentina. He is a member of the Board of Directors of International Society of Endovascular Specialists (ISES). He is active member of national and international scientific societies (e.g. European Society of Cardiology, American College of Cardiology, Spanish Association of Cardiology, and Latin American Association of Interventional Cardiologists). Prof. Dr. Ivo Petrov is Chairman of the Bulgarian Society for Endovascular Therapy.
Enterprise Technology Architect, University Hospital Zurich
Radoy Pavlov has lived and worked abroad for more than 20 years. He currently holds the position of Enterprise Technology Architect in one of the largest healthcare facilities in Switzerland – the University Hospital Zurich. As a member of the management team, he participated in the drawing of the future digitalization map for the development of the hospital and the 44 specialized clinics adjacent to it. The themes included in this plan are derivatives of the new reality after COVID, as well as the Swiss national health initiative “eHealth 2.0”.
Radoy is a former director, program and platform manager at UBS Bank. He has also held senior consulting positions at Infosys Consulting, Lodestone and Capco. In addition to his expertise in architectural topics, he is a cloud and infrastructure specialist. Radoy is an honorary member of the DHI Cluster Bulgaria. He is a graduate of the Technical University of Berlin with a degree in computer technology.
Pioneer and a global innovator in the image recognition
Imagga Technologies Ltd. (Imagga) is a pioneer and a global innovator in the image recognition as a service space.The company has been offering its cloud API since 2014 and its on-premise solution since 2015.The algorithms behind these products have been in active development since 2012. The company’s image recognition technologies are currently used by more than 24,000 developers and 200 companies worldwide, and Imagga has received numerous international awards and recognitions as the best technology provider at South Summit’ 15 from the HB King of Spain, global champion in the news and media category at the UN World Summit Awards ’16 and global innovator in the category Image Analytics ’16 from IDC, among other awards. The company’s solutions are recognized as some of the most accurate on the market worldwide, surpassing competitors such as Google Cloud Vision and Amazon Recognition based on an independent assessment of technology by a renowned Israeli university.
During the COVID-19 pandemic in March 2020, Imagga co-founded Kelvin Health Inc., an artificial intelligence thermal imaging company, with the ambitious goal of making remote screening of a number of conditions and diseases as easy and harmless as taking selfies. This allows the prevention of complications and gives the ability to detect many unsuspected health conditions.
Internationally recognized digital healthcare company providing the full-cycle digital transformation services
BGO Software guide our clients in making informed decisions, assist them in building their ICT strategy, and provide the capacity to execute it. Our international teams successfully manage projects for customers across the UK, Europe, Switzerland and the United States.
Since 2008, BGO has grown to become a trusted Digital Solutions Consultant and Provider of various private enterprises, governmental organizations, and institutions. We are currently a Strategic Partner and Vendor for numerous Fortune 500 Pharma companies with a proven methodology for Project Management and Delivery of complex solutions, from CONCEPT TO LAUNCH.
Combining innovation, technology, and niche industry know-how we also develop our own products with a focus on Digital Transformation & Acceleration of Digilization in the Healthcare Industry.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives
The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system.
Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders.
The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries. In 2019, Roche invested CHF 11.7 billion in R&D and posted sales of CHF 61.5 billion.
Global, science-led biopharmaceutical company
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal and Metabolism, and Respiratory and Immunology.
AstraZeneca has more than 50 years in Bulgaria and is one of the dynamic and fastest growing companies in the industry.
AstraZeneca Bulgaria launches socially responsible initiatives aimed at improving the health and quality of life and unlocking the potential of young people.
Digital health is one of main priorities of the company. Years of experience enabling AstraZeneca to embed digital health at scale across R&D. To improve patients experience and outcomes and shortening the time it takes to bring life-changing medicines to patients, AstraZeneca have three strategic priorities: transforming how the company works, redefining digital health and reimagining healthcare.
Leader in core virtualization, management and automation, availability, disaster recovery and analytics
VMware established its representative office in Bulgaria in 2007 and has since then become one of the largest IT investors in the country. With an increased workforce of more than five times over the past thirteen years and with an in-depth expertise in core virtualization, management and automation, availability, disaster recovery and analytics, the Sofia team is crucial for serving the needs of some of the world’s largest businesses. In 2014, the first VMware centre for professional software services for integration, automation and personalized solutions was created in Sofia, working with clients and partners around the world.
A dedicated Bulgarian employer, VMware attracts talent globally with its work on cutting edge technologies and projects with global impact, multiple programs and initiatives for personal and professional development. The Sofia team employees some of the world’s best experts in software development, product management, quality engineering and technical publications but also business operations expertise within the growing financial and business services team, offering in-depth skills around finance, business analytics and business intelligence.
All of this has transformed VMware’s Bulgaria operations from an R&D facility to a multifunctional hub with product, revenue generating professional services and business operations teams.
We transform new ideas and discoveries into innovative medicines and therapies to combat serious and socially significant diseases
Being a biotech company, Amgen is unleashing the potential of biology for the benefit of patients suffering from serious diseases by discovering, developing, manufacturing and supplying innovative medicines for human use. This approach is based on the use of tools such as the highest advances in human genetics to unravel the complex nature of disease and to gain an in-depth understanding of the basics of human biology.
Amgen focuses its efforts on unresolved medical issues and uses its expertise in organic production to find solutions that improve treatment outcomes and significantly change the quality of life. A pioneer in biotechnology since 1980, Amgen has grown to become one of the largest independent biotechnology companies with millions of patients in more than 75 countries around the world.
Since 2009, Amgen has been working in Bulgaria in partnership with the Bulgarian scientific community and healthcare institutions to provide access to vital medicines and to patients in the country. In addition, the company sponsors numerous clinical trials.
B EYE is а specialized analytics, connected planning, and automation development factory. Since 2012, we have been helping global Pharmaceutical and Medical Device companies to democratize their data and embed analytics and planning into the fabric of their organizations. Our goal is to make these faster, cheaper, easier, and make it large-scale:
In 2020, B EYE was recognized by the Financial Times as one of the “1000 Fastest growing companies in Europe”.
MY Synergy is a company focused on providing services in healthcare consulting, IT services and digital marketing. Leader on guiding companies, NGOs, and governments through the dynamics of exponential change in the health & tech markets, helping HCPs design and manage their approach to the healthcare system. Our company enables business development, optimization and digital transformation in the healthcare industry by providing expertise and digital solutions based on extensive knowledge, experience and detailed analytical information. The complex solutions and services offered are result of a detailed analysis and tailored selection of innovative technologies to meet the specific needs and high expectations of our clients with added value to their business.
Our mission is to develop, optimize and automate healthcare with the necessary innovative and digital solutions to reach every healthcare facility in the world.
MY Synergy is a Microsoft Certified Partner and a key healthcare solution and consulting provider in the CEE region.
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture.
Bayer‘s products and services are designed to benefit people and improve their quality of life. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen.
Bayer Bulgaria EOOD is mainly marketing and commercial organization for pharmaceutical products, OTC products and crop protection products (herbicides, fungicides, and insecticides) and seeds. In addition, Bayer Bulgaria EOOD is engaged in clinical trials in relation to its pharmaceutical products. Bayer’s mission is Science for a Better Life!
Play Reha is an online platform for rehabilitation. It greatly facilitates the postoperative recovery of the patient by providing him/her with quality, comfortable to use and affordable rehabilitation. The platform offers rehabilitation and rehabilitation programs created by Bulgarian specialists, orthopedists and rehabilitators. The programs are playlists with exercises specifically designed to restore the health of the patient with the associated pathology. They last between 20 and 90 days. The platform offers great opportunities to tailor individual programs to the needs of each patient. Recovery programs aim to strengthen the general body of the patient and help prevent a variety of diseases of the musculoskeletal system.
Murgova & Partners Law Company is a leading law firm in Bulgaria with extensive experience in advising international and local clients in the areas of corporate and company law, healthcare, mergers and acquisitions, labor law, public procurement, litigation in court proceedings, etc.
We offer a full range of legal services ranging from setting up commercial companies through the provision of legal advice related to specific corporate and commercial matters, such as transaction structuring, analysis and due diligence, to the provision of legal subscription services on a daily basis.
We also specialize in areas directly related to healthcare, including clinical trials, procurement procedures for medical products and equipment. We take the services provided by the law firm to a higher level by providing legal services on the most up-to-date topics in the field of personal data protection, anti-money laundering and trade secrets. The members of our firm have extensive experience in the sector, and the managing partner is a lawyer. Petya Murgova has been specializing in healthcare for over 15 years.
Healee is a telemedicine platform that provides an interactive link for online consultation between doctors and patients across the country. Patients can consult with doctors from all over the country online, with access to specialized care fast, easy and timely. They can use the application for a variety of illnesses and symptoms without having to queue with other sick people in healthcare settings. Doctors can consult online and provide written advice.
The telemedicine platform provides rich physician-patient communication capabilities and allows any type of data to be sent: chat, live video chat, medical imaging (including dynamic such as MRI), lab results, symptoms, vital signs, and treatment appointment, primary and control examinations. All this is stored in the patient file and easily accessible for inspection by the patient and if needed by other doctors.
Healee also offers a virtual service – artificial intelligence guided Healee Chatbot, a smarter alternative to digging into Google for symptoms. The Healee Chatbot provides information on possible causes as well as guidance on what to do with a symptom.
SAT Health is a certified pharma information and technology provider, operating on the Bulgarian market and performing:
Our mission is to provide excellence in data processing, big data management and evidence-based consulting. All based and supported by state-of-the-art modern technology. SAT Health is certified by Lloyd’s Register, in accordance with ISO 27001/2017 for “Gathering, processing and analyzing data for pharmaceutical market and delivery of consulting services and solutions to healthcare organizations”.
Check Point Cardio is an innovative Bulgarian company that produces a complete system for remote monitoring of patients. It consists of three components – a hardware device placed on a person’s body, software that digitizes information from live metrics in real time and sends it via Bluethooth to a mobile application. Subsequently, the application sends data to a server in a cloud platform through which physicians can monitor patients’ condition. A smartphone is also included in the system, which transmits real-time data and provides the patient with an additional opportunity to call the physician who is monitoring his/her condition in case of anxiety.
Monitors for individual use follow 24/7 over 8 vital indicators. They can be used for home monitoring of a patient’s condition by measuring heart rate, blood pressure, heart rate pressure, saturation (blood saturation with oxygen) of the blood, breathing, body temperature and at what position and activity the body stays. The monitors are also certified for use in a hospital setting, with the ability to replace hospital equipment.
We are MeRck, a vibrant science and technology company. Science is at the heart of everything we do. It drives the discoveries we make and the technologies we create. Our work makes a positive difference to millions of people’s lives every day. In Healthcare, we discover unique ways to treat the most challenging diseases such as multiple sclerosis and cancer.
Our Life Science experts empower scientists by developing tools and solutions that help deliver breakthroughs more quickly. And in Performance Materials, we develop science that sits inside technologies and changes the way we access and display information. Everything we do is fueled by a belief in science and technology as a force for good. A belief that has driven our work since 1668, and will continue to inspire us to find more joyful and sustainable ways to live.
Merck has been active in Bulgaria since 1992, when the first representation was opened. As of November 2009, all business operations of Merck in Healthcare and Life Science Business are managed by Merck Bulgaria EAD, the local direct subsidiary of Merck KGaA, Darmstadt.
Mnemonica specializes in providing information security and regulatory compatibility, data management and storage, cloud technologies and virtualization, managed services and IT outsourcing. Among its customers are the top 10 financial institutions and the leading telecoms in Bulgaria.
Since its founding in 2009, Mnemonica has successfully implemented more than 600 projects for 100+ customers in Bulgaria and abroad and positively influencing the jobs of over 100,000 employees from many different organizations. Since 2017, Mnemonica’s team has been assisting Bulgarian companies in their preparation for the General Data Protection Regulation (GDPR).
MSD operates in Bulgaria for more than 20 years. Since the beginning MSD works purposefully in providing access to innovative health solutions. Our efforts are concentrated in immune oncology development – area with potential to become not only new treatment paradigm in cancer but also a new hope for longer and better patient life.
MSD Bulgaria collaborates with scientific and patient societies in developing and providing an innovative solutions which helps people living with Hepatitis C and HIV. In terms of prophylaxis MSD shares the strive of increasing the number of vaccinated people and provides the widest access to innovative vaccines for major unmet health needs. Together with our innovation orientation we as MSD are working also for humanitarian campaigns. Emphasizing our culture of social responsibility every year MSD employees are committing hundreds of hours volunteer work for improvement of health and welfare of society.
In MSD Bulgaria we are aspiring to put innovative approach in our daily work and one of our main priorities is to become the first digital leader in communications with our external partners, society an internally in company – between the employees. We have committed our efforts to implement innovative approach in everything we do to help improve health and wellbeing of the people all over the world – to expand access to healthcare, to follow high ethical standards in our work, care for the environment and to engage our employees.
CORP-1235366-0000, © Copyright 2018, Merck Sharp & Dohme Bulgaria EOOD, affiliate of Merck & Co., Inc., Kenilworth, NJ, USA. All rights reserved.
Concento Ltd. is a technology company developing a cloud-based platform for the 21st century healthcare industry.
Our vision for the future: Increase trust between doctor and patient by greatly improving and regulating communication between them. We enable all stakeholders in the healthcare process to work together – doctors, pharmacists, dentists, healthcare professionals, patients, administrators, agents, insurers, and all other related businesses. We place the patient at the center of the system and work to create paperless healthcare. We have the ambition to become the largest healthcare online-platform in Bulgaria and Eastern Europe.
Bulgarian Pharmaceutical Union (BPhU) is the legally represented professional organization of the Master of Pharmacists in Bulgaria. BPhU was founded in accordance with the Law on the Professional Organization of the Master of Pharmacists and its membership is a necessary and indispensable condition for exercising the profession of master-pharmacist.
The Bulgarian Medical Association (BMA) is the professional association of doctors in Bulgaria. The legalization of BMA as a separate legal organization took place after the adoption of the Law on Professional Organizations of Doctors and Doctors of Dental Medicine in 1999. According to the law, professional organizations of doctors and dentists – the Bulgarian Medical Association (BMA) and the Bulgarian Dental Association (BDA) are established, their arrangements, their organization and their activities, the conditions for exercising the medical and dental profession and the responsibility for violation of professional ethics are regulated. It is assumed by law that all doctors who practice their profession must be members of the BMA.
The doctors’ organization is actively involved in the health-political processes in the country, is responsible for drafting a Code of professional ethics for doctors, exercises control over their observance, elaborates the Rules for Good Medical Practice and is a party to the negotiation of the financial and operational practs of the medical profession through the signing of an annual National Framework Contract.
For 20 years now, JA Bulgaria has been a leading educational organization in Bulgaria, a member of a global network with an established reputation for providing innovative and modern 21st-century education to students from kindergarten to university. Our portfolio of educational products and services features programs in 3 thematic areas: entrepreneurship, financial literacy and employability skills.
JA uses the Progression model “From ABC to PhD” – a spiral approach of education as a way to create sustainable entrepreneurial competencies. JA’s philosophy of teaching and learning is based on learning by doing and blended classroom using digital interactive content and high technologies. The business model of the organization features close collaboration with the business sector and practitioners who participate in the creation and delivery of educational content, training and services, and policy development in education and entrepreneurship.
JA Bulgaria is a member of JA Worldwide and JA Europe and reaches 30,000 students from 450 locations in the country annually.
Novartis is a pharmaceutical company created in Switzerland in 1996 through a merger of Ciba-Geigy and Sandoz. Novartis and its predecessor companies trace roots back more than 250 years, with a rich history of developing innovative products. Novartis uses science-based innovation to address some of society’s most challenging healthcare issues. Novartis discovers and develops breakthrough treatments and finds new ways to deliver them to as many patients as possible.
In 2017 Novartis invested about €4.5m in R&D and infrastructure in Bulgaria. This investment includes 67 clinical trials, 27 of them in Oncology, which have provided access to innovative therapies and clinical monitoring for 1500 Bulgarian patients. Novartis has almost 200 medicinal products in its portfolio in Bulgaria. Novartis is a key partner of healthcare professionals, patients, institutions and society.
FindMeCure is a next-generation platform allowing every person struggling with a medical condition to access treatments in development. We created and apply a unique matching algorithm that easily connects people worldwide with the most suitable studies for them in order to help:
Established in 2000 as part of Sirma Group, Ontotext is a leading global provider of semantic technology products and solutions. Ontotext helps various types of data and content-intensive businesses to make the most out of their structured and unstructured data by interlinking them both for the sake of more efficient metadata management, information discovery and advanced analytics.
Ontotext value-added solutions are spread wide across Pharma and Healthcare companies value chain – covering complex semantic data integration solutions in drug discovery, drug development and manufacturing, drug safety and regulatory reporting. Our customers are top-tier pharma & biotech companies, science and technology publishers, media and financial information publishing, market intelligence and government organizations
National Patients’ Organization is the largest patient umbrella association in Bulgaria unifying more than 85 organizations devoted to various socially significant and rare diseases. NPO is a full member of the European Patients’ Forum (EPF) and the International Alliance of Patients’ Organizations (IAPO).
National Patients’ Organization is also one of the main initiators for the establishment of the Patient Access Partnership (PACT) and the Bulgarian “Health Partnership” – consultative body to the Council of Ministers to cooperate in developing and implementing public health policies and improving access to timely, adequate and effective medical services for citizens.
Sqilline’s business is focused on the development of technologies and solutions in the fields of services, healthcare and pharmaceutical industry. The company’s team has created Danny Platform – one of the first Analytics Healthcare platform for real-world data for two of the largest health areas in Central and Eastern Europe – oncology and cardiology.
The solution provides real-time aggregated analyses of structured and unstructured health data with integration of registries, external clinical and drug databases, etc. It utilizes proprietary algorithms and methodologies for data quality, data validation and predictive insights based on de-identified patient records.Danny Platform can also analyse how specific factors influence and improve patient treatment and compare the effectiveness of different regimens to achieve better patient care. Sqilline is a leading SAP Partner in Europe in the areas of Precision Medicine, Life Science and Healthcare.
Superdoc and Healee each cater to a distinct aspect of patient – doctor communication, but both aspire to make healthcare accessible, reliable and less complicated for everyone involved.
With Superdoc patients find the appropriate specialist in their geographic area, read verified reviews and book online appointments directly in the doctor’s calendar. Doctors gain new patients, greatly improve online visibility, never miss an appointment request, and optimize schedule and workload.
AbbVie is a research-based global biopharmaceutical company. The mission of the company is to discover and develop transformative therapies that deliver compelling patient benefits, strong clinical performance and clear economic value, while reshaping the standard of care for patients. In 2013, AbbVie became a separate company from Abbott (founded in 1888), though sharing a common legacy and strong prospects for future success.
In 2018, AbbVie medicines helped over 30 million patients in more than 175+ countries. More than 30 000 employees work in the company worldwide. AbbVie is a leader in immunology. The company has been leveraging deep scientific expertise to develop next-generation biologics and small molecules in rheumatology, dermatology and gastroenterology. Oncology is the fastest growing therapeutic area from AbbVie’s portfolio. AbbVie may have been founded in 2013, but its roots run deep.
SoftGroup is a Bulgarian software company that creates technological solutions in order to prevent one of the global challenges in the field of pharmaceutical industry, namely the medical counterfeiting. This process is carried out by SoftGroup® SaTT (Serialization and Track&Trace) – a mass serialization system and centralized management of pharmaceutical packaging.
The main focus of our work is to create a complete solution tailored to European specifics as well as Russian requirements – software, hardware and all other related services as support issues. Founded in 2003, today the company is a well-established partner of many pharmaceutical companies in Bulgaria, Germany, Ireland, Czech Republic, Poland, Iceland, Slovakia, Russia, Cyprus, Romania and North Macedonia.
Service Centrix Ltd. was founded in 2008 by proven IT professionals with many years of experience in large international companies. Our team is motivated to provide you with innovative and complete solutions that can meet your requirements, using the latest technologies to optimize cost and support your business development.
We at Service Centrix focus on IT Service Management, security and risk management, business process management, infrastructure optimization and automation. The main goal of our team is to understand and satisfy the business needs of our customers.
Our mission is to empower business focus on the key drivers by enabling seamless IT processes throughout the organization. The high level of services we offer is a constant goal of Service Centrix. Concentrating on some of the industry standards and best practices such as ITIL, CobiT, ISO20000, ISO 2700x, TOGAF, PMBOK, Agile /Scrum, DevOps, BABOK and CMMI, we offer the best combination to meet our specific customer requirements. Our goal is to identify, evaluate and control risks to ensure the reliability of IT operations that are critical to an organization’s business functions.